5. VySpine earned FDA clearance for its LumiVy OsteoVy PEKK lumbar interbody fusion device. The device was cleared for use in intervertebral body fusion at one or two contiguous levels to treat ...
Centinel Spine's prodisc L has "extremely low" long-term rates of revision and adjacent-level surgery, according to a study of 1,187 patients. 1. Researchers included 1,187 patients who had lumbar ...
Angitia Biopharmaceuticals ("Angitia” or "the Company”), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases ...
Theradaptive, a privately held, clinical stage biologics company developing protein therapeutics for spine, orthopedics, soft tissue repair, and targeted immuno-oncology, announced today that the US ...
The spinal implants market is witnessing robust growth, driven by an increasing prevalence of spinal disorders, advancements in medical technology, and a rising geriatric population. This article ...
The following is a summary of “Incidence and duration of human papillomavirus infections in young women: insights from a bimonthly follow-up cohort,” published in the November 2024 issue of Infectious ...